Bluensomycin

DB20923ExperimentalSmall molecule

Bluensomycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Bluensomycin is a antibiotic, produced by Streptomyces strain. Bluensomycin has a monoisotopic...

Formula / weight: C₂₁H₃₉N₅O₁₄ · 585.564 g/mol (avg)
Code names: U-12898

Resolves to

Compound

UNIILWV7PWE57UCAS11011-72-6ChEMBLCHEMBL2104642ChEBI81193KEGGC17573

Structure

InChIKeyRQLDKUSQKQMFCN-AEXVNIBOSA-NSMILES

[H][C@@]1(O[C@H]2[C@H](O)[C@@H](O)[C@H](OC(N)=O)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@](O)(CO)[C@H]1O[C@]1([H])O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1NC

Which companies are running trials of Bluensomycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account